-transparent.png){kind=logo}
OBJECTIVE Lipoprotein (a) [Lp (a)] is an atherogenic particle that structurally resembles a low-density lipoprotein (LDL) particle but contains a molecule of apolipoprotein (a) attached to apolipoprotein B-100 by a disulfide bond. Because of the fact that elevated plasma levels of Lp (a) have been shown to be an independent risk factor for coronary artery disease (CAD), we determined plasma Lp(a) levels in CAD for Turkish population, and compared them with previous findings of some developed countries. RESULTS The mean plasma Lp (a) levels in CAD group (mean +/- SD; 0.41 +/- 0.21, g/L) was found approximately twofold higher than that of the control group (0.21 +/- 0.17 g/L). Also, it was found to be higher than the mean levels of CAD group in the other populations described in previous reports. But CAD prevalence in the Turkish population is lower than in those of developed countries, especially the United States. CONCLUSIONS We concluded that the interaction between plasma Lp (a) levels and many other factors such as face and heredity affecting development of CAD may show different effects for development of CAD in each of those populations separately.
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
March 1992,
Annals of clinical biochemistry,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
December 1998,
The American journal of cardiology,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
February 1986,
Atherosclerosis,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
July 1999,
Kidney international. Supplement,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
January 2001,
American journal of critical care : an official publication, American Association of Critical-Care Nurses,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
June 1995,
Journal of cardiovascular risk,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
November 2000,
La Tunisie medicale,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
July 2005,
The New England journal of medicine,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
November 1986,
JAMA,
A Orem, and
O Değer, and
K Kulan, and
E Onder, and
E Kiran, and
D Uzunosmanoğlu
January 2011,
Journal of internal medicine,
